(Total Views: 83)
Posted On: 10/17/2022 10:06:07 AM
Post# of 27136

$AVXL News Article - Anavex Life Sciences Announces Late-Breaking Presentation of Phase 2b/3 Data of Oral ANAVEX 2-73 (blarcamesine) for Early Alzheimer's Disease at the Upcoming Clinical Trials on Alzheimer's Disease (CTAD) Congress 2022 https://marketwirenews.com/news-releases/anav...35140.html


My Twitter: WhyteStocks